Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients. / Lynggaard, Charlotte Duch; Jersie-Christensen, Rosa; Juhl, Morten; Jensen, Siri Beier; Grønhøj, Christian; Melchiors, Jacob; Jacobsen, Søren; Møller-Hansen, Michael; Herly, Mikkel; Ekblond, Annette; Kastrup, Jens; Fischer-Nielsen, Anne; Belstrøm, Daniel; von Buchwald, Christian.
In: Communications Medicine, Vol. 2, 160, 2022.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Intraglandular mesenchymal stem cell treatment induces changes in the salivary proteome of irradiated patients
AU - Lynggaard, Charlotte Duch
AU - Jersie-Christensen, Rosa
AU - Juhl, Morten
AU - Jensen, Siri Beier
AU - Grønhøj, Christian
AU - Melchiors, Jacob
AU - Jacobsen, Søren
AU - Møller-Hansen, Michael
AU - Herly, Mikkel
AU - Ekblond, Annette
AU - Kastrup, Jens
AU - Fischer-Nielsen, Anne
AU - Belstrøm, Daniel
AU - von Buchwald, Christian
N1 - © 2022. The Author(s).
PY - 2022
Y1 - 2022
N2 - BACKGROUND: Hyposalivation and xerostomia (dry mouth), are the leading site-effects to treatment of head and neck cancer. Currently, there are no effective therapies to alleviate radiation-induced hyposalivation. Adipose tissue-derived mesenchymal stem/stromal cells (AT-MSCs) have shown potential for restoring salivary gland function. However, the mode of action is unknown. The purpose of the present study was therefore to characterize the effect of AT-MSC therapy on the salivary proteome in previously irradiated head and neck cancer patients.METHODS: Whole saliva was collected from patients with radiation-induced salivary gland hypofunction (n = 8) at baseline, and 120 days after AT-MSC treatment, and from healthy controls (n = 10). The salivary proteome was characterized with mass spectrometry based proteomics, and data was compared within the AT-MSC group (baseline versus day 120) and between AT-MSC group and healthy controls. Significance levels between groups were determined by using double-sided t-test, and visualized by means of principal component analysis, volcano plots and cluster analysis.RESULTS: Here we show that 140 human proteins are significantly differentially expressed in saliva from patients with radiation-induced hypofunction versus healthy controls. AT-MSC treatment induce a significant impact on the salivary proteome, as 99 proteins are differentially expressed at baseline vs. 120 days after treatment. However, AT-MSC treatment does not restore healthy conditions, as 212 proteins are significantly differentially expressed in saliva 120 days after AT-MSCs treatment, as compared to healthy controls.CONCLUSION: The results indicate an increase in proteins related to tissue regeneration in AT-MSCs treated patients. Our study demonstrates the impact of AT-MSCs on the salivary proteome, thereby providing insight into the potential mode of action of this novel treatment approach.
AB - BACKGROUND: Hyposalivation and xerostomia (dry mouth), are the leading site-effects to treatment of head and neck cancer. Currently, there are no effective therapies to alleviate radiation-induced hyposalivation. Adipose tissue-derived mesenchymal stem/stromal cells (AT-MSCs) have shown potential for restoring salivary gland function. However, the mode of action is unknown. The purpose of the present study was therefore to characterize the effect of AT-MSC therapy on the salivary proteome in previously irradiated head and neck cancer patients.METHODS: Whole saliva was collected from patients with radiation-induced salivary gland hypofunction (n = 8) at baseline, and 120 days after AT-MSC treatment, and from healthy controls (n = 10). The salivary proteome was characterized with mass spectrometry based proteomics, and data was compared within the AT-MSC group (baseline versus day 120) and between AT-MSC group and healthy controls. Significance levels between groups were determined by using double-sided t-test, and visualized by means of principal component analysis, volcano plots and cluster analysis.RESULTS: Here we show that 140 human proteins are significantly differentially expressed in saliva from patients with radiation-induced hypofunction versus healthy controls. AT-MSC treatment induce a significant impact on the salivary proteome, as 99 proteins are differentially expressed at baseline vs. 120 days after treatment. However, AT-MSC treatment does not restore healthy conditions, as 212 proteins are significantly differentially expressed in saliva 120 days after AT-MSCs treatment, as compared to healthy controls.CONCLUSION: The results indicate an increase in proteins related to tissue regeneration in AT-MSCs treated patients. Our study demonstrates the impact of AT-MSCs on the salivary proteome, thereby providing insight into the potential mode of action of this novel treatment approach.
U2 - 10.1038/s43856-022-00223-3
DO - 10.1038/s43856-022-00223-3
M3 - Journal article
C2 - 36496530
VL - 2
JO - Communications Medicine
JF - Communications Medicine
SN - 2730-664X
M1 - 160
ER -
ID: 345513944